Spectrum Brands, Madison, said Monday it has paid $50 million cash to buy a majority 56 percent interest in Shaser Bioscience, a privately owned Boston company developing “energy-based, aesthetic dermatological technology for home use devices.”
Thomas O’Guinn, professor of marketing at the UW-Madison School of Business, questioned the diversity that will be added to Spectrum Brands’ already broad list of products. But he said the acquisition represents a growing market. “This is getting into a space that is almost medical device, but not exactly. That is not where I expected Spectrum to go,” O’Guinn said.